Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-21-030175
Filing Date
2021-12-01
Accepted
2021-12-01 14:28:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 641710
2 form424b5_001.jpg GRAPHIC 5956
3 form424b5_002.jpg GRAPHIC 5964
  Complete submission text file 0001493152-21-030175.txt   659477
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

EIN.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-232798 | Film No.: 211462521
SIC: 2834 Pharmaceutical Preparations